HealthEquity (NASDAQ: HQY) reported Q3 EPS of $0.28, $0.03 better than the analyst estimate of $0.25. Revenue for the quarter came in at $70.5 million versus the consensus estimate of $69.65 million.

• Revenue of $70.5 million, an increase of 24% compared to Q3 FY18.
• Net income of $15.7 million, an increase of 50% compared to Q3 FY18.
• Net income per diluted share of $0.25 compared to $0.17 in Q3 FY18.
• Non-GAAP net income per diluted share of $0.28 compared to $0.17 in Q3 FY18.
• Adjusted EBITDA of $29.7 million, an increase of 40% compared to Q3 FY18.
• HSA Members of 3.7 million, an increase of 22% compared to Q3 FY18.
• Total Custodial Assets of $7.1 billion, an increase of 27% compared to Q3 FY18.

“HealthEquity delivered robust third quarter results, strengthening our momentum going into the important fourth quarter and year end,” said Jon Kessler, President and CEO of HealthEquity. “By adding more than $1.5 billion in additional custodial assets since the end of our third quarter last year, our growth continues well ahead of the market, allowing us to raise guidance for fiscal year 2019. Importantly, with custodial investment assets growing by 53% over the third quarter end last year, we are delivering on our promise to help our HSA members connect health and wealth and put them on the fast track to retirement readiness.”

GUIDANCE:

HealthEquity sees FY2019 EPS of $1.06-$1.13, versus the consensus of $1.11. HealthEquity sees FY2019 revenue of $281-285 million, versus the consensus of $283.99 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.